Business
Presentation of Prototype Wearable
Presentation of Prototype Wearable.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 9572T Cambridge Cognition Holdings PLC 04 April 2016 \n\n04 April 2016\nCambridge Cognition Holdings Plc\n('Cambridge Cognition' or the 'Company')\n \nFirst showing of groundbreaking mental health wearable Cognition Kit™ at Neurotech Investing Conference\n \nThe neuroscience technology company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG) and research design experts Ctrl Group Limited (London, UK) are presenting the first prototype of a ground-breaking new software application to improve the understanding, diagnosis and treatment of mental health ahead of schedule on April 7 at the Neurotech Investing and Partnering Conference in Boston, MA.\n \nHaving reached prototype stage earlier than anticipated, the two companies are now set to form a joint venture called Cognition Kit to accelerate development of cognitive testing applications for wearable and smart devices for use in pharmaceutical research programmes and general healthcare. The Cognition Kit™ platform will enable doctors, scientists and the public to better understand and manage day-to-day brain health; empowering people to detect changes in cognitive wellbeing and take action faster.\n \nCognition Kit technology gathers rich physical and neurological health data during everyday life. Over time, the software learns how each individual's mood and cognitive performance varies moment-to-moment and the factors that contribute to their wellness, such as sleep, stress and physical activity. This will create a more natural and accurate profile of a person's mental health helping people track their wellbeing, intervene if their health declines and lead fuller, more active lives.\n \nCurrent methods of cognitive assessment, whether in the laboratory or in the clinic, rely on infrequent snapshots to characterise profiles of impairment, recovery and decline. Such sparse sampling of behaviour will often miss clinically significant changes, which can impact on quality of life and limit the ability to quantify the effects of neurological and medical conditions and their treatments. \n \nCognition Kit technology has the potential to bring high-frequency measurement to patients and provide them with tools to monitor daily variations in their cognitive health and link these to data about their lifestyle, medicatio...